WGSWW
GeneDx Holdings Corp.Key Statistics
About GeneDx Holdings Corp.
GeneDx Holdings Corp. (Ticker: WGSWW) is a leader in the genomics sector, focusing on genomic testing and precision medicine to diagnose rare and complex genetic disorders. By harnessing advanced sequencing technologies and a robust genetic database, GeneDx empowers healthcare providers with critical diagnostic insights that support personalized treatment strategies. Its comprehensive portfolio of genetic tests, alongside strategic alliances within the healthcare industry, positions the company favorably in the marketplace and highlights its dedication to transforming personalized medicine, ultimately enhancing patient care outcomes through innovative genetic healthcare solutions.
Fundamentals
| Revenue (TTM) | $442.68M |
| Gross Profit (TTM) | $307.91M |
| EBITDA | $-7.85M |
| Operating Margin | -25.60% |
| Return on Equity | -30.40% |
| Return on Assets | -4.37% |
| Revenue/Share (TTM) | $15.30 |
| Book Value | $8.57 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 17.40% |
| Shares Outstanding | 0 |
| Float | $18.94M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on WGSWW and any ticker you trade — then tracks every position and per-strategy win rate.